BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23945591)

  • 1. Biological techniques: An embryonic view of tumour development.
    Schweiger PJ; Jensen KB
    Nature; 2013 Sep; 501(7466):171-2. PubMed ID: 23945591
    [No Abstract]   [Full Text] [Related]  

  • 2. Mouse models: Novel in vivo RNAi screen in mice.
    Lokody I
    Nat Rev Cancer; 2013 Oct; 13(10):682. PubMed ID: 24030505
    [No Abstract]   [Full Text] [Related]  

  • 3. RNAi screens in mice identify physiological regulators of oncogenic growth.
    Beronja S; Janki P; Heller E; Lien WH; Keyes BE; Oshimori N; Fuchs E
    Nature; 2013 Sep; 501(7466):185-90. PubMed ID: 23945586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation from unconventional 5' start sites drives tumour initiation.
    Sendoel A; Dunn JG; Rodriguez EH; Naik S; Gomez NC; Hurwitz B; Levorse J; Dill BD; Schramek D; Molina H; Weissman JS; Fuchs E
    Nature; 2017 Jan; 541(7638):494-499. PubMed ID: 28077873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling Cooperative Tumorigenesis in
    Richardson HE; Portela M
    Biomed Res Int; 2018; 2018():4258387. PubMed ID: 29693007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA in carcinogenesis & cancer diagnostics: a new paradigm.
    Ahmad J; Hasnain SE; Siddiqui MA; Ahamed M; Musarrat J; Al-Khedhairy AA
    Indian J Med Res; 2013 Apr; 137(4):680-94. PubMed ID: 23703335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.
    Al-Rugeebah A; Alanazi M; Parine NR
    Pathol Oncol Res; 2019 Jul; 25(3):859-874. PubMed ID: 30793226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response.
    Baker SG
    J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766402
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNAs Determining Carcinogenesis by Regulating Oncogenes and Tumor Suppressor Genes During Cell Cycle.
    Fasoulakis Z; Daskalakis G; Diakosavvas M; Papapanagiotou I; Theodora M; Bourazan A; Alatzidou D; Pagkalos A; Kontomanolis EN
    Microrna; 2020; 9(2):82-92. PubMed ID: 31538910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: a cancer theory kerfuffle can lead to new lines of research.
    Kaye FJ
    J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766401
    [No Abstract]   [Full Text] [Related]  

  • 11. CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.
    Xin Y; Li Z; Shen J; Chan MT; Wu WK
    Cell Prolif; 2016 Jun; 49(3):255-60. PubMed ID: 27134049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?
    Soto AM; Sonnenschein C
    Bioessays; 2014 Jan; 36(1):118-20. PubMed ID: 24323923
    [No Abstract]   [Full Text] [Related]  

  • 13. The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis.
    Pearson HB; McGlinn E; Phesse TJ; Schlüter H; Srikumar A; Gödde NJ; Woelwer CB; Ryan A; Phillips WA; Ernst M; Kaur P; Humbert P
    Mol Cancer; 2015 Sep; 14():169. PubMed ID: 26376988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Cancer Models in Zebrafish.
    Casey MJ; Stewart RA
    Trends Cancer; 2020 May; 6(5):407-418. PubMed ID: 32348736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPAG5: An Emerging Oncogene.
    He J; Green AR; Li Y; Chan SYT; Liu DX
    Trends Cancer; 2020 Jul; 6(7):543-547. PubMed ID: 32291236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cancer a breakdown of multicellularity?
    Pennisi E
    Science; 2018 Jun; 360(6396):1391. PubMed ID: 29954963
    [No Abstract]   [Full Text] [Related]  

  • 17. CRNDE: An important oncogenic long non-coding RNA in human cancers.
    Zhang J; Yin M; Peng G; Zhao Y
    Cell Prolif; 2018 Jun; 51(3):e12440. PubMed ID: 29405523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras-Mediated Activation of NF-κB and DNA Damage Response in Carcinogenesis.
    Ahmad A; Ahsan H
    Cancer Invest; 2020 Apr; 38(4):185-208. PubMed ID: 31971023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational patterns in oncogenes and tumour suppressors.
    Baeissa HM; Benstead-Hume G; Richardson CJ; Pearl FM
    Biochem Soc Trans; 2016 Jun; 44(3):925-31. PubMed ID: 27284061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.